ANNX - Annexon Inc.

-

$undefined

N/A

(N/A)

Annexon Inc. NASDAQ:ANNX Annexon, Inc., doing business as Annexon Biosciences, operates as a clinical-stage biopharmaceutical company. The Company develops novel therapies for auto-immune and neurodegenerative diseases of body, eye, and brain. Annexon Biosciences serves patients in the State of California.

Location: | Website: www.annexonbio.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

330.3M

Cash

368.7M

Avg Qtr Burn

-25.44M

Short % of Float

11.29%

Insider Ownership

0.50%

Institutional Own.

-

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
ANX005 (IV) Details
Guillian-Barre syndrome, Autoimmune disease

BLA

Submission

ANX007 (IVT) Details
Geographic atrophy

Phase 3

Data readout

ANX005 (IV) Details
Brain disease, Huntington's disease

Phase 3

Initiation

ANX005 (IV) Details
Amyotrophic lateral sclerosis, Neurodegenerative disease

Phase 2a

Update

ANX009 Details
Lupus nephritis

Phase 1b

Update

ANX105 Details
Autoimmune disease, Neurodegenerative disease

Phase 1

Data readout

ANX1502 Details
Autoimmune disease, Cold agglutinin disease

Phase 1a

Data readout

ANX005 (IV) Details
Warm autoimmune hemolytic anemia, Autoimmune disease

Failed

Discontinued